Hepatitis C: the cure the NHS cannot afford
NHS England is worried they cannot afford a drug that cures hepatitis C in 90 per cent of cases, taking the unusual step of asking its roll-out to be delayed.
NHS England is worried they cannot afford a drug that cures hepatitis C in 90 per cent of cases, taking the unusual step of asking its roll-out to be delayed.